MedTrace Logo

Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy

NCT04755764 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2025-05-13

No results posted yet for this study

Summary

The purpose of the research is to characterize the effect of labetalol, atenolol, and nifedipine on maternal hemodynamics early in pregnancy. Patients will be given medication based on their hemodynamics and asked to return for a repeat measurement.

Conditions

  • Systolic Hypertension
  • Pregnancy Related
  • Diastolic Hypertension
  • Cardiac Output, Low
  • Cardiac Output, High

Interventions

DRUG

Labetalol

Beta blocker

DRUG

Atenolol

Beta blocker

DRUG

Nifedipine

Calcium channel blocker

Sponsors & Collaborators

  • Marshall University

    lead OTHER

Principal Investigators

  • Jesse Cottrell, MD · Marshall University

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-03
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04755764 on ClinicalTrials.gov